142 related articles for article (PubMed ID: 37555536)
1. Synthetic Heparanase Inhibitors Can Prevent Herpes Simplex Viral Spread.
Chopra P; Yadavalli T; Palmieri F; Jongkees SAK; Unione L; Shukla D; Boons GJ
Angew Chem Int Ed Engl; 2023 Oct; 62(41):e202309838. PubMed ID: 37555536
[TBL] [Abstract][Full Text] [Related]
2. Heparanase-Regulated Syndecan-1 Shedding Facilitates Herpes Simplex Virus 1 Egress.
Hadigal S; Koganti R; Yadavalli T; Agelidis A; Suryawanshi R; Shukla D
J Virol; 2020 Feb; 94(6):. PubMed ID: 31827001
[TBL] [Abstract][Full Text] [Related]
3. Heparanase is a host enzyme required for herpes simplex virus-1 release from cells.
Hadigal SR; Agelidis AM; Karasneh GA; Antoine TE; Yakoub AM; Ramani VC; Djalilian AR; Sanderson RD; Shukla D
Nat Commun; 2015 Apr; 6():6985. PubMed ID: 25912399
[TBL] [Abstract][Full Text] [Related]
4. Host Enzymes Heparanase and Cathepsin L Promote Herpes Simplex Virus 2 Release from Cells.
Hopkins J; Yadavalli T; Agelidis AM; Shukla D
J Virol; 2018 Dec; 92(23):. PubMed ID: 30232188
[TBL] [Abstract][Full Text] [Related]
5. Role of Heparanase and Syndecan-1 in HSV-1 Release from Infected Cells.
Sharma P; Kapoor D; Shukla D
Viruses; 2022 Sep; 14(10):. PubMed ID: 36298711
[TBL] [Abstract][Full Text] [Related]
6. Heparanase-Induced Activation of AKT Stabilizes β-Catenin and Modulates Wnt/β-Catenin Signaling during Herpes Simplex Virus 1 Infection.
Koujah L; Madavaraju K; Agelidis AM; Patil CD; Shukla D
mBio; 2021 Dec; 12(6):e0279221. PubMed ID: 34749529
[TBL] [Abstract][Full Text] [Related]
7. Heparanase, Heparan Sulfate and Viral Infection.
Agelidis A; Shukla D
Adv Exp Med Biol; 2020; 1221():759-770. PubMed ID: 32274736
[TBL] [Abstract][Full Text] [Related]
8. Exploring Heparanase Levels in Tears: Insights From Herpes Simplex Virus-1 Keratitis Patients and Animal Studies.
Gagan S; Khapuinamai A; Kapoor D; Sharma P; Yadavalli T; Joseph J; Shukla D; Bagga B
Invest Ophthalmol Vis Sci; 2024 Mar; 65(3):7. PubMed ID: 38466284
[TBL] [Abstract][Full Text] [Related]
9. Using a 3-O-sulfated heparin octasaccharide to inhibit the entry of herpes simplex virus type 1.
Copeland R; Balasubramaniam A; Tiwari V; Zhang F; Bridges A; Linhardt RJ; Shukla D; Liu J
Biochemistry; 2008 May; 47(21):5774-83. PubMed ID: 18457417
[TBL] [Abstract][Full Text] [Related]
10. Protease, Growth Factor, and Heparanase-Mediated Syndecan-1 Shedding Leads to Enhanced HSV-1 Egress.
Karasneh GA; Kapoor D; Bellamkonda N; Patil CD; Shukla D
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578329
[TBL] [Abstract][Full Text] [Related]
11. Viral Activation of Heparanase Drives Pathogenesis of Herpes Simplex Virus-1.
Agelidis AM; Hadigal SR; Jaishankar D; Shukla D
Cell Rep; 2017 Jul; 20(2):439-450. PubMed ID: 28700944
[TBL] [Abstract][Full Text] [Related]
12. Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo.
Tiwari V; Liu J; Valyi-Nagy T; Shukla D
J Biol Chem; 2011 Jul; 286(28):25406-15. PubMed ID: 21596749
[TBL] [Abstract][Full Text] [Related]
13. CREB3 Plays an Important Role in HPSE-Facilitated HSV-1 Release in Human Corneal Epithelial Cells.
Yadavalli T; Sharma P; Wu D; Kapoor D; Shukla D
Viruses; 2022 May; 14(6):. PubMed ID: 35746643
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of 3-O-sulfonated heparan sulfate octasaccharides that inhibit the herpes simplex virus type 1 host-cell interaction.
Hu YP; Lin SY; Huang CY; Zulueta MM; Liu JY; Chang W; Hung SC
Nat Chem; 2011 Jun; 3(7):557-63. PubMed ID: 21697878
[TBL] [Abstract][Full Text] [Related]
15. Role for 3-O-sulfated heparan sulfate as the receptor for herpes simplex virus type 1 entry into primary human corneal fibroblasts.
Tiwari V; Clement C; Xu D; Valyi-Nagy T; Yue BY; Liu J; Shukla D
J Virol; 2006 Sep; 80(18):8970-80. PubMed ID: 16940509
[TBL] [Abstract][Full Text] [Related]
16. Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate.
Vlodavsky I; Ilan N; Naggi A; Casu B
Curr Pharm Des; 2007; 13(20):2057-73. PubMed ID: 17627539
[TBL] [Abstract][Full Text] [Related]
17. λ-Carrageenan Oligosaccharides of Distinct Anti-Heparanase and Anticoagulant Activities Inhibit MDA-MB-231 Breast Cancer Cell Migration.
Groult H; Cousin R; Chot-Plassot C; Maura M; Bridiau N; Piot JM; Maugard T; Fruitier-Arnaudin I
Mar Drugs; 2019 Feb; 17(3):. PubMed ID: 30818840
[TBL] [Abstract][Full Text] [Related]
18. The 3-
Chopra P; Joshi A; Wu J; Lu W; Yadavalli T; Wolfert MA; Shukla D; Zaia J; Boons GJ
Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33441484
[TBL] [Abstract][Full Text] [Related]
19. The low molecular weight heparan sulfate-mimetic, PI-88, inhibits cell-to-cell spread of herpes simplex virus.
Nyberg K; Ekblad M; Bergström T; Freeman C; Parish CR; Ferro V; Trybala E
Antiviral Res; 2004 Jul; 63(1):15-24. PubMed ID: 15196816
[TBL] [Abstract][Full Text] [Related]
20. Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b.
Rux AH; Lou H; Lambris JD; Friedman HM; Eisenberg RJ; Cohen GH
Virology; 2002 Mar; 294(2):324-32. PubMed ID: 12009874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
